X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Fulford India Fact Sheet, Fulford India Financial Results - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Fulford India Fact Sheet   (FLFD)

Here is the latest financial fact sheet of Fulford India. For more details, see the Fulford India quarterly results and Fulford India share price and chart. For a sector overview, read our pharmaceuticals sector report.

FULFORD INDIA Price History

Price Rs 2,362.0
Mkt Cap Rs m 9,212
Vol '000 3.3
P/E X 398.8
P/CF X 153.8
EPS (TTM) Rs 5.9
% ch % 0.0
No. of shares m 3.90
% ch week % 0.9
% ch 1-mth % 5.3
% ch 12-mth % 44.0
52 week H/L Rs 2,365.0/1,100.0
(As on Jul 30, 2015 (Close))
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

FULFORD INDIA Financials

No. of Mths
Year Ending
12
Dec-09
*
12
Dec-10
*
12
Dec-11
*
12
Dec-12
*
15
Mar-14
*
5-Yr Chart
Click to enlarge
FULFORD INDIA EQUITY SHARE DATA
High Rs8441,2731,064958942 
Low Rs272787389452450 
Sales per share (Unadj.) Rs471.5487.7549.2552.2691.4 
Earnings per share (Unadj.) Rs34.530.94.7-12.811.5 
Diluted earnings per shareRs34.530.94.7-12.811.5 
Cash flow per share (Unadj.) Rs37.335.09.1-8.415.4 
Dividends per share (Unadj.) Rs4.504.503.501.002.00 
Adj. dividends per shareRs4.504.503.501.002.00 
Dividend yield (eoy) %0.80.40.50.10.3 
Book value per share (Unadj.) Rs358.6384.2384.9370.9380.0 
Adj. book value per shareRs358.6384.2384.9370.9380.0 
Shares outstanding (eoy) m3.903.903.903.903.90 
Bonus/Rights/Conversions  ----- 
Price / Sales ratio x1.22.11.31.31.0 
Avg P/E ratio x16.233.3154.0-55.160.7 
P/CF ratio (eoy) x15.029.579.8-83.645.3 
Price / Book Value ratio x1.62.71.91.91.8 
Dividend payout %13.014.674.2-7.817.4 
Avg Mkt Cap Rs m2,1764,0182,8332,7502,714 
No. of employees `0000.40.50.50.50.4 
Total wages/salary Rs m286332420451505 
Avg. sales/employee Rs Th4,132.63,850.24,284.04,524.66,073.0 
Avg. wages/employee Rs Th642.2671.5839.0947.31,137.4 
Avg. net profit/employee Rs Th302.7243.936.8-104.8100.7 
FULFORD INDIA INCOME DATA
Net Sales Rs m1,8391,9022,1422,1542,696 
Other income Rs m68799497125 
Total revenues Rs m1,9071,9812,2362,2502,822 
Gross profit Rs m166114-49-152-46 
Depreciation Rs m1116171715 
Interest Rs m031010 
Profit before tax Rs m22317427-7354 
Minority Interest Rs m00000 
Prior Period Items Rs m-20000 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m86539-2310 
Profit after tax Rs m13512118-5045 
Gross profit margin %9.06.0-2.3-7.0-1.7 
Effective tax rate %38.630.731.931.217.7 
Net profit margin %7.36.30.9-2.31.7 
FULFORD INDIA BALANCE SHEET DATA
Current assets Rs m1,5481,8411,9201,7251,738 
Current liabilities Rs m367424616513545 
Net working cap to sales %64.274.560.956.244.3 
Current ratio x4.24.33.13.43.2 
Inventory Days Days7163767648 
Debtors Days Days292216114 
Net fixed assets Rs m5655422712 
Share capital Rs m3939393939 
"Free" reserves Rs m1,3591,4591,4621,4081,443 
Net worth Rs m1,3981,4991,5011,4471,482 
Long term debt Rs m00000 
Total assets Rs m1,7661,9232,1622,0092,077 
Interest coverage xNM61.039.6-180.36.7 
Debt to equity ratio x00000 
Sales to assets ratio x1.01.01.01.11.3 
Return on assets %7.66.40.9-2.52.6 
Return on equity %9.68.01.2-3.43.0 
Return on capital %15.811.81.8-5.04.3 
Exports to sales %00000 
Imports to sales %36.628.536.532.924.5 
Exports (fob) Rs m00000 
Imports (cif) Rs m673542781708659 
Fx inflow Rs m001917 
Fx outflow Rs m1,097558812727673 
Net fx Rs m-1,097-558-811-718-656 
FULFORD INDIA CASH FLOW
From Operations Rs m -45 60 112 -266 90 
From Investments Rs m 7 180 78 85 105 
From Financial Activity Rs m -9 -23 -21 -16 -14 
Net Cashflow Rs m -47 216 169 -198 181 
* Results Consolidated
Source: Company Annual Reports, Regulatory Filings, Equitymaster

FULFORD INDIA Raw Materials Data

ITEM Rs m % To R.M.C. % To SALES
Antibiotics 20.0 89.3 0.7
Others 2.4 10.7 0.1

Share Holding

Indian Promoters 0.0%
Foreign collaborators 75.0%
Indian inst/Mut Fund 3.8%
FIIs 0.1%
ADR/GDR 0.0%
Free float 21.2%
Shareholders 4,783
Pledged promoter(s) holding 0.0%
 

Company Information

REGD OFF Platina, 8th Floor, Plot No. C-59, G-Block, B. K. C, Bandra (E), Mumbai-400 098
E-MAIL sachin.gaikwad@merck.com WEB www.fulfordindia.com
TELEPHONE (022) 6789 8888 FAX (022) 6789 8889
SECTOR PHARMACEUTICALS GROUP M N C
TR AGENT Link Intime India, C13, Pannalal Silk Mills Compd., LBS Marg, Mumbai-78
AUDITOR Lovelock & Lewes
CHM: Ajit Dangi COMP SEC: Sachin A. Gaikwad YEAR OF INC: 1948 BSE CODE: 506803 FV (Rs): 10 DIV YIELD (%): 0.1

More Pharmaceuticals Company Fact Sheets:   PIRAMAL ENTERPRISES  NOVARTIS  GLENMARK PHARMA  SUN PHARMA  NATCO PHARMA  

Compare FULFORD INDIA With:   PIRAMAL ENTERPRISES  NOVARTIS  GLENMARK PHARMA  SUN PHARMA  NATCO PHARMA  

Compare FULFORD INDIA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes Flat in Final Hour Sell Off; HDFC Twins Surge(Closing)

Indian share markets witnessed selling pressure in the final hour of trade but still closed at a record high for a third straight session.

Views on news

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

Sun Pharma: Price Erosion in US Impacts Growth (Quarterly Results Update - Detailed)

May 30, 2017

US markets decline while other geographies grow in the quarter.

Lupin: Decline in US Business Impacts Overall Growth (Quarterly Results Update - Detailed)

May 29, 2017

Currency fluctuation and one time provision impacts operating margins.

Glenmark Pharma: Lower Zetia Sales leads to Subdued Growth (Quarterly Results Update - Detailed)

May 18, 2017

Base price erosion in the US and lower Zetia sales impacts profits.

Sun Pharma: Slow Growth Across Major Markets (Quarterly Results Update - Detailed)

Mar 11, 2017

Sun Pharma has announced its December quarter (3QFY17) results. The company has reported 8% YoY growth in sales and a decline of 4.7% YoY in the net profits.

More Views on News

Most Popular

Ride the Bull Wave with These Perfect Proxies to India's Growth Story(The 5 Minute Wrapup)

Jul 15, 2017

The secret of spotting multibaggers before they become a hit.

The Real Returns from Real Estate Have Been Very Low(Vivek Kaul's Diary)

Jul 17, 2017

Real estate prices across India have barely gone anywhere over the last four years. Prices have fallen in many cities over the last one-year, new data from the National Housing Bank suggests.

Trade the Markets like Roger Federer Plays Tennis(Daily Profit Hunter)

Jul 19, 2017

Trading is one of the most competitive fields in the world today. To win, you must adopt the mindset of a Grand Slam champion.

Sold Your Immoveable Property? Here Are The Tax Implications...(Outside View)

Jul 19, 2017

When you're selling an immoveable property, it becomes imperative to recognise the intricate tax implications.

Why Keeping Unrealistic Expectations From Investments Is Stupid!(Outside View)

Jul 18, 2017

When investing, keeping realistic returns is necessary and it is not the only thing you should look at.

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK FULFORD INDIA

  • Track your investment in FULFORD INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON FULFORD INDIA

FULFORD INDIA - PIRAMAL ENTERPRISES COMPARISON

COMPARE FULFORD INDIA WITH

MARKET STATS